Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Inomagen Therapeutics announced it raised $200,000 in an initial filing from an offering of $6.63 Million
PRIVATEApr 12, 2024•over 2 years ago
Amount Raised
$200,000
Round Type
Pre-Seed
ChicagoBiotechnologyDon't miss Inomagen Therapeutics's next move
Get an email the moment Inomagen Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contactFunding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Inomagen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.